A trend in acquired drug resistances of tuberculosis patients registered in health centers from 1981 to 2004

Tuberculosis and Respiratory Diseases

Volumn 59, Issue 6, 2005, Pages 619-624

  Chang, Chulhun L ^a,c   Lee, Eun Yup ^a   Park, Soon Kew ^a   Jeong, Seok Hoon ^b   Park, Young Kil ^c   Choi, Yong Woon ^c   Kim, Hee Jin ^c   Lew, Woo Jin ^c   Bai, Gill Han ^c,d  

^a Pusan National University School of Medicine   (South Korea)

^b Kosin University   (South Korea)

^c Korean Institute of Tuberculosis   (South Korea)

^d NONE   (South Korea)

Author keywords

Acquired drug resistance; Multidrug resistance; Tuberculosis

Indexed keywords

AMINOSALICYLIC ACID; CYCLOSERINE; ETHAMBUTOL; ISONIAZID; KANAMYCIN; OFLOXACIN; PROTIONAMIDE; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERACTINOMYCIN; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BACTERIUM ISOLATE; CHILD; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG SENSITIVITY; FEMALE; GENDER; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATIENT COMPLIANCE; RURAL AREA; TREATMENT FAILURE; TUBERCULOSIS; URBAN AREA;

EID: 33644691599     PISSN: 17383536     EISSN: None     Source Type: Journal    
DOI: 10.4046/trd.2005.59.6.619     Document Type: Article

References (6)

1. Espinal MA, Laszlo A, Simonsen L, Boulahbal F, Kim SJ, Reniero A, et al. Global trends in resistance to anti tuberculosis Health Organization- International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med 2001;344:1294-303.
2. Pablos-Mendez A, Raviglione MC, Laszlo A, Binkin N, Rieder HL, Bustreo F, et al. Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Antituberculosis Drug Resistance Surveillance. N Engl J Med 1998;338:1641-9.
3. Korean National Tuberculosis Association. 2004 Annual Report; 2005.
4. World Health Organization. Anti-tuberculosis drug resistance in the world. The third global report. The WHO/IUATLD global project on anti-tuberculosis drug resistance surveillance 1999-2002. Geneva: World Health Organization; 2004.
5. Inderlied CB, Pfyffer GE. Susceptibility test method Mycobacteria. In: Murray PR, Baron EJ, Pfaller MA, Jorgensen JH, Yolken RH, editors. Manual of clinical microbiology. 8th ed. Washington, D.C.: American Society for Microbiology; 2003. p. 1149-77.
6. Jeong SH, Lee DD, Choi J-C, Kim S, Shin JH, Jeong J, et al. Multi-center study on cost effectiveness of anti-tuberculosis drug susceptibility test. Infect Chemother 2005;37:16-21.